BioCardia, Inc.
BCDA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000925741
In the last 90 days, BioCardia, Inc. insiders filed 9 open-market purchases and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in BioCardia, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −2 vs. Q4 2023
- Shares held
- 1.95M
- −112.0K (−5.4%) vs. Q4 2023
- Total value
- $790.8K
- −$574.4K (−42.1%) vs. Q4 2023
- New holders
- 3
- 5 more added
- Sold out
- 5
- 4 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCDA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $1.65M |
| Q1 2026 | 18 | $831.1K |
| Q4 2025 | 20 | $812.3K |
| Q3 2025 | 18 | $551.9K |
| Q2 2025 | 16 | $593.2K |
| Q1 2025 | 12 | $623.8K |
| Q4 2024 | 13 | $272.2K |
| Q3 2024 | 9 | $316.6K |
| Q2 2024 | 10 | $227.8K |
| Q1 2024 | 22 | $790.8K |
| Q4 2023 | 24 | $1.37M |
| Q3 2023 | 16 | $709.6K |
| Q2 2023 | 23 | $4.43M |
| Q1 2023 | 23 | $4.09M |
| Q4 2022 | 25 | $4.87M |
| Q3 2022 | 23 | $3.17M |
| Q2 2022 | 26 | $3.10M |
| Q1 2022 | 24 | $5.49M |
| Q4 2021 | 23 | $5.78M |
| Q3 2021 | 22 | $9.01M |
| Q2 2021 | 20 | $12.3M |
| Q1 2021 | 19 | $13.5M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding BioCardia, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 113 | $0 | 0.00% | −110−49.3% | Reduced |
| Wells Fargo & Company | 109 | $44 | 0.00% | +11+11.2% | Added |
| Tower Research Capital LLC (TRC) | 311 | $127 | 0.00% | +71+29.6% | Added |
| Morgan Stanley | 450 | $183 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 7,207 | $2.00K | 0.00% | +7,207 | New |
| Global Retirement Partners, LLC | 6,177 | $2.51K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 6,528 | $2.66K | 0.00% | −16−0.2% | Reduced |
| Octavia Wealth Advisors, LLC | 14,238 | $5.79K | 0.00% | +14,238 | New |
| Virtu Financial LLC | 14,053 | $6.00K | 0.00% | −27,295−66.0% | Reduced |
| Wedbush Securities Inc | 15,000 | $6.00K | 0.00% | 00.0% | Unchanged |
| Pingora Partners LLC | 15,605 | $6.35K | 0.00% | +8,188+110.4% | Added |
| Northern Trust Corp | 19,226 | $7.83K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 21,000 | $8.55K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 21,373 | $8.70K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 30,000 | $12.0K | 0.00% | +4,000+15.4% | Added |
| Brown Advisory Inc | 33,085 | $13.5K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 45,891 | $18.7K | 0.00% | +3,124+7.3% | Added |
| Family Management Corp | 77,500 | $31.5K | 0.01% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 111,079 | $45.2K | 0.00% | +111,079 | New |
| Geode Capital Management, LLC | 155,859 | $63.4K | 0.00% | −3,789−2.4% | Reduced |
| Vanguard Group Inc | 650,763 | $264.9K | 0.00% | 00.0% | Unchanged |
| CM Management, LLC | 700,000 | $284.9K | 0.24% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −88,300−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −65,426−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −33,629−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −23,032−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −18,335−100.0% | Sold out |